Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...

The new gapfill price of $2,007 per test will positively impact long-term margins, with an expected increase in average selling price to $1,300 in 2025.

Read More

Did you find this insightful?